SRPT
Sarepta Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.63B
P/E Ratio
44.06
EPS
$0.35
Beta
0.20
52W High
$25.32
52W Low
$10.42
50-Day MA
$19.44
200-Day MA
$19.77
Dividend Yield
—
Profit Margin
2.98%
Forward P/E
4.88
PEG Ratio
159.25
About Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.18B |
| Gross Profit (TTM) | $470.80M |
| EBITDA | $46.18M |
| Operating Margin | 49.00% |
| Return on Equity | 4.91% |
| Return on Assets | 0.02% |
| Revenue/Share (TTM) | $21.41 |
| Book Value | $14.26 |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 0.74 |
| EV/Revenue | 0.901 |
| EV/EBITDA | 15.74 |
| Quarterly Earnings Growth (YoY) | 2664.00% |
| Quarterly Revenue Growth (YoY) | -1.90% |
| Shares Outstanding | $105.58M |
| Float | $94.61M |
| % Insiders | 4.21% |
| % Institutions | 99.05% |
Historical Volatility
HV 10-Day
57.30%
HV 20-Day
52.68%
HV 30-Day
57.27%
HV 60-Day
84.86%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($22.00 target)
8
Buy12
Hold3
Sell2
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026